Balasa Dinverno & Foltz LLC boosted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 47.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,539 shares of the company’s stock after buying an additional 1,455 shares during the period. Balasa Dinverno & Foltz LLC’s holdings in Colgate-Palmolive were worth $332,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of the stock. Quest Investment Management Inc. OR raised its position in shares of Colgate-Palmolive by 10.5% in the fourth quarter. Quest Investment Management Inc. OR now owns 76,609 shares of the company’s stock worth $5,013,000 after buying an additional 7,292 shares during the last quarter. Chickasaw Capital Management LLC raised its position in shares of Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after buying an additional 11,605 shares during the last quarter. Meritage Portfolio Management raised its position in shares of Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after buying an additional 255 shares during the last quarter. Eastern Bank raised its position in shares of Colgate-Palmolive by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock worth $801,000 after buying an additional 89 shares during the last quarter. Finally, ProShare Advisors LLC raised its position in shares of Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after buying an additional 79,323 shares during the last quarter. 73.74% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company (CL) traded down 0.17% during trading on Friday, reaching $71.48. The company’s stock had a trading volume of 2,297,297 shares. The company has a market cap of $62.96 billion, a P/E ratio of 26.56 and a beta of 0.80. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The company’s 50 day moving average price is $73.87 and its 200 day moving average price is $72.62.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.70 EPS. On average, equities analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, July 14th. This represents a $1.60 annualized dividend and a yield of 2.24%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive Company (NYSE:CL) Shares Bought by Balasa Dinverno & Foltz LLC” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/04/colgate-palmolive-company-nysecl-stake-increased-by-balasa-dinverno-foltz-llc-updated-updated-updated.html.

Several equities research analysts have recently weighed in on CL shares. Bank of America Corporation raised their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, May 31st. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a research note on Wednesday, May 17th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $76.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $75.82.

In other Colgate-Palmolive news, Director Ellen M. Hancock sold 5,057 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $71.91, for a total transaction of $363,648.87. Following the sale, the director now directly owns 199,777 shares of the company’s stock, valued at approximately $14,365,964.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $71.53, for a total transaction of $1,001,420.00. Following the sale, the senior vice president now directly owns 102,838 shares in the company, valued at $7,356,002.14. The disclosure for this sale can be found here. Insiders have sold a total of 117,097 shares of company stock worth $8,480,638 over the last three months. Insiders own 1.02% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.